Article Details

HC Wainwright Cuts Galmed Pharmaceuticals (NASDAQ:GLMD) Price Target to $25.00

Retrieved on: 2021-03-19 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

HC Wainwright Cuts Galmed Pharmaceuticals (NASDAQ:GLMD) Price Target to $25.00. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 115,800 shares of the biopharmaceutical company's stock worth $360,000 after acquiring an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up